Peptide Vaccination Against PD-L1 and PD-L2 in Relapsed Follicular Lymphoma
Clinical trial NCT03381768 · COMPLETED
Trial details
- NCT number
- NCT03381768
- Sponsor
- Lars Møller Pedersen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-12
- Primary completion
- 2020-02-12
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.